D.G. Knapen

Faculty of Medical Sciences

Telephone:

E-mail:

d.g.knapen umcg.nl

Research Portal

Publications

89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice

Broer, L. N. , Knapen, D. G. , Suurs, F. V. , Moen, I. , Giesen, D. , Waaijer, S. J. H. , Indrevoll, B. , Ellingsen, C. , Kristian, A. , Cuthbertson, A. S. , de Groot, D-J. A. , Cole, P. E. , de Vries, E. G. E. , Hagemann, U. B. & Lub-de Hooge, M. N. , 1-Nov-2022 , In: The Journal of Nuclear Medicine. 63 , 11 , p. 1715-1721 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Abstract CT207: A phase 1 open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a Trispecific Humabody® T-cell enhancer, in patients with PSMA+ advanced and/or metastatic solid tumors (POTENTIA)

de Bono, J. S. , Arkenau, H-T. , Gort, E. H. , Devriese, L. L. , Fontana, E. , Knapen, D. G. , Tiu, C. , Williams, A. , de Groot, D. J. A. , Gunaydin, U. M. , Bartlett, P. , Pierce, A. J. , Bland-Ward, P. , Hashimoto, K. & de Vries, E. G. E. , 1-Jun-2022 , In: Cancer Research. 82 , 12_Supplement , p. CT207-CT207

Research output: Contribution to journal › Meeting Abstract › Academic

Molecular imaging to support cancer immunotherapy

van de Donk, P. P. , Oosting, S. F. , Knapen, D. G. , van der Wekken, A. J. , Brouwers, A. H. , Lub-de Hooge, M. N. , de Groot, D-J. A. & de Vries, E. G. E. , 3-Aug-2022 , In: Journal for immunotherapy of cancer. 10 , 8 , 10 p. , 004949.

Research output: Contribution to journal › Review article › peer-review

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

Knapen, D. G. , Cherny, N. I. , Zygoura, P. , Latino, N. J. , Douillard, J-Y. , Dafni, U. , de Vries, E. G. E. & Groot, de, D. J. , 6-Sept-2020 , In: ESMO Open. 5 , 5 , 10 p. , e000681.

Research output: Contribution to journal › Article › Academic › peer-review

Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?

Knapen, D. G. , de Groot, D. J. A. , Kwee, T. C. , Meijne, E. I. M. , Fehrmann, R. S. N. & de Vries, E. G. E. , Jul-2020 , In: CANCER TREATMENT REVIEWS. 87 , 4 p. , 102027.

Research output: Contribution to journal › Review article › peer-review

All (8) publications

Press/media

Podcast over het coloncarcinoom

Daan Knapen

11/04/2022

Press/Media: Expert Comment › Professional

Podcast about "Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale"